Jim Simons
ANIX icon

Jim Simons’s Anixa Biosciences ANIX Stock Holding History

Jim Simons’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$158K Buy
61,173
+7,300
+14% +$21.6K ﹤0.01% 2956
2025
Q4 		$168K Buy
53,873
+11,109
+26% +$45.5K ﹤0.01% 2913
2025
Q3 		$141K Buy
42,764
+15,091
+55% +$47.7K ﹤0.01% 3205
2025
Q2 		$91.3K Buy
27,673
+6,200
+29% +$17.7K ﹤0.01% 3314
2025
Q1 		$61.4K Buy
21,473
+6,900
+47% +$19.7K ﹤0.01% 3269
2024
Q4 		$33.8K Buy
14,573
+3,900
+37% +$12.1K ﹤0.01% 3436
2024
Q3 		$33.6K Buy
+10,673
New +$32.8K ﹤0.01% 3387
2024
Q2 		– Sell
-68,800
Closed -$215K – 3467
2024
Q1 		$215K Buy
+68,800
New +$274K ﹤0.01% 3205
2023
Q4 		– Sell
-10,000
Closed -$33K – 3715
2023
Q3 		$33K Sell
10,000
-49,300
-83% -$173K ﹤0.01% 3460
2023
Q2 		$190K Buy
59,300
+37,998
+178% +$146K ﹤0.01% 3316
2023
Q1 		$92K Sell
21,302
-26,598
-56% -$116K ﹤0.01% 3512
2022
Q4 		$204K Sell
47,900
-9,300
-16% -$44.7K ﹤0.01% 3407
2022
Q3 		$281K Sell
57,200
-28,682
-33% -$116K ﹤0.01% 3240
2022
Q2 		$263K Sell
85,882
-138,773
-62% -$438K ﹤0.01% 3522
2022
Q1 		$616K Sell
224,655
-106,145
-32% -$311K ﹤0.01% 3047
2021
Q4 		$982K Buy
330,800
+118,600
+56% +$480K ﹤0.01% 2654
2021
Q3 		$1.01M Buy
212,200
+87,701
+70% +$396K ﹤0.01% 2543
2021
Q2 		$483K Buy
+124,499
New +$530K ﹤0.01% 2978
2020
Q2 		– Sell
-32,216
Closed -$51K – 3414
2020
Q1 		$51K Buy
+32,216
New +$94.4K ﹤0.01% 3320

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jim Simons's ANIX Position: Q1 2026 in Review

Jim Simons increased its Anixa Biosciences (ANIX) stake by 14% in Q1 2026, buying an estimated $21.6K and bringing the position to 61,173 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #2956.

Jim Simons first reported a position in ANIX in Q1 2020 and has held it in 19 quarters since. The position peaked at $1.01M in Q3 2021. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Jim Simons held 61,173 shares of Anixa Biosciences worth $158K as of Q1 2026.
  • Jim Simons bought 7,300 Anixa Biosciences shares in Q1 2026, an estimated $21.6K.
  • Anixa Biosciences made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2956 holding.
  • Jim Simons first reported a position in Anixa Biosciences in Q1 2020 and has held it in 19 quarters since.
  • Jim Simons's Anixa Biosciences position peaked at $1.01M in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.